Risperidone: an open-label, observational study of the efficacy, tolerability, and prescribing behavior in acutely exacerbated patients with schizophrenia.
作者:
主题词
急性病(Acute Disease);投药, 口服(Administration, Oral);成年人(Adult);抗精神病药(Antipsychotic Agents);药物疗法, 联合(Drug Therapy, Combination);女(雌)性(Female);敌意(Hostility);人类(Humans);男(雄)性(Male);中年人(Middle Aged);观察(Observation);前瞻性研究(Prospective Studies);精神病状态评定量表(Psychiatric Status Rating Scales);利哌立酮(Risperidone);精神分裂症(Schizophrenia);治疗结果(Treatment Outcome)
DOI
10.1097/01.jcp.0000170686.27476.ab
PMID
16012270
发布时间
2019-09-11
- 浏览35
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文